The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
Open accessAbstract
The response to endocrine therapy in breast cancer correlates with estrogen receptor (ER) and progesterone receptor (PR) status. ER-positive/PR-negative breast cancers respond less well to selective ER modulator (SERM) therapy than ER-positive/PR-positive tumors. The predictive value of PR has long been attributed to the dependence of PR expression on ER activity, with the absence of PR reflecting a nonfunctional ER and resistance to hormonal therapy. However, recent clinical and laboratory evidence suggests that ER-positive/PR-negative breast cancers may be specifically resistant to SERMs, whereas they may be less resistant to estrogen withdrawal therapy with aromatase inhibitors, which is a result inconsistent with the nonfunctional ER theory. Novel alternative molecular mechanisms potentially explaining SERM resistance in ER-positive/PR-negative tumors have been suggested by recent experimental indications that growth factors may downregulate PR levels. Thus, the absence of PR may not simply indicate a lack of ER activity, but rather may reflect hyperactive cross talk between ER and growth factor signaling pathways that downregulate PR even as they activate other ER functions. Therefore, ER-positive/PR-negative breast tumors might best be treated by completely blocking ER action via estrogen withdrawal with aromatase inhibitors, by targeted ER degradation, or by combined therapy targeting both ER and growth factor signaling pathways. In this review, we will discuss the biology and etiology of ER-positive/PR-negative breast cancer, highlighting recent data on molecular cross talk between ER and growth factor signaling pathways and demonstrating how PR might be a useful marker of these activities. Finally, we will consider the clinical implications of these observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wong, C.-W., McNally, C., Nickbarg, E., Komm, B. S., & Cheskis, B. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192569699 · Cited by 324
RetractedWriting Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Self-citationActivation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Anderson, R. G. W. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.199 · Cited by 1,942
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Shou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E., Ali, S., Weiss, H., & Schiff, R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh166 · Cited by 1,153
Self-citationMolecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Razandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0239 · Cited by 1,040
Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α
Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Constantinidou, D., Ali, S., & Nakshatri, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010840200 · Cited by 968
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Estrogen receptor pathways to AP-1
Kushner, P. J., Agard, D. A., Greene, G. L., Scanlan, T. S., Shiau, A. K., Uht, R. M., & Webb, P. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00108-4 · Cited by 870
The ATAC (Arimidex, T. A. O. I. C. T. G. (2003) · Cancer · doi:10.1002/cncr.11745 · Cited by 861
Horwitz, K. B., & McGuire, W. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38062-6 · Cited by 799
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
Self-citationBardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
Self-citationCDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720
The value of estrogen and progesterone receptors in the treatment of breast cancer
Osborne, C. K., Yochmowitz, M. G., Knight, W. A., & McGuire, W. L. (1980) · Cancer · doi:10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u · Cited by 720
Self-citationSmith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660
Self-citationKonecny, G., Pauletti, G., Pegram, M., Untch, M., Dandekar, S., Aguilar, Z., Wilson, C., Rong, H.-M., Bauerfeind, I., Felber, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.142 · Cited by 588
Anderson, W. F., Chatterjee, N., Ershler, W. B., & Brawley, O. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020299707510 · Cited by 585
Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis
Horowitz, K. B., McGuire, W. L., Pearson, O. H., & Segaloff, A. (1975) · Science · doi:10.1126/science.168640 · Cited by 569
Baek, S. H., Ohgi, K. A., Rose, D. W., Koo, E. H., Glass, C. K., & Rosenfeld, M. G. (2002) · Cell · doi:10.1016/s0092-8674(02)00809-7 · Cited by 558
Risk Factors for Breast Cancer According to Estrogen and Progesterone Receptor Status
Colditz, G. A., Rosner, B. A., Chen, W. Y., Holmes, M. D., & Hankinson, S. E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh025 · Cited by 533
Membrane estrogen receptors identified by multiple antibody labeling and impeded‐ligand binding
Pappas, T. C., Gametchu, B., & Watson, C. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896011 · Cited by 529
Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2002-220620 · Cited by 521
HER-2 gene amplification can be acquired as breast cancer progresses
Meng, S., Tripathy, D., Shete, S., Ashfaq, R., Haley, B., Perkins, S., Beitsch, P., Khan, A., Euhus, D., Osborne, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402993101 · Cited by 508
Self-citationReview of the in Vivo Functions of the p160 Steroid Receptor Coactivator Family
Xu, J., & Li, Q. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0116 · Cited by 493
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
Fan, S., Wang, J.-A., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., Pestell, R. G., Yuan, F., Auborn, K. J., Goldberg, I. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1354 · Cited by 491
Gutierrez, M. C., Detre, S., Johnston, S., Mohsin, S. K., Shou, J., Allred, D. C., Schiff, R., Osborne, C. K., & Dowsett, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.172 · Cited by 489
Self-citationArpino, G., Weiss, H., Lee, A. V., Schiff, R., De Placido, S., Osborne, C. K., & Elledge, R. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji249 · Cited by 484
Self-citationEstrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway
Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., & Grohé, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910345199 · Cited by 474
Li, L., Haynes, M. P., & Bender, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831079100 · Cited by 465
Schiff, R., Massarweh, S. A., Shou, J., Bharwani, L., Mohsin, S. K., & Osborne, C. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-031212 · Cited by 462
Self-citationAronica, S. M. (1993) · Molecular Endocrinology · doi:10.1210/me.7.6.743 · Cited by 456
Le Goff, P., Montano, M. M., Schodin, D. J., & Katzenellenbogen, B. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41801-1 · Cited by 452
Ali, S., Metzger, D., Bornert, J. M., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05756.x · Cited by 448
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Font de Mora, J., & Brown, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5041-5047.2000 · Cited by 432
Klein-Hitpass, L., Ryffel, G. U., Heitlinger, E., & Cato, A. C. B. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.2.647 · Cited by 429
Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 422
Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions
Safe, S. (2001) · Vitamins & Hormones · doi:10.1016/s0083-6729(01)62006-5 · Cited by 418
Histological and biological evolution of human premalignant breast disease.
Allred, D. C., Mohsin, S. K., & Fuqua, S. A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080047 · Cited by 416
Song, R. X.-D., McPherson, R. A., Adam, L., Bao, Y., Shupnik, M., Kumar, R., & Santen, R. J. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0748 · Cited by 407
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
and members of the Southeast Sweden Breast Cancer Group, Pérez-Tenorio, G., & Stål, O. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600126 · Cited by 394
Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 392
Stewart, A. J., Johnson, M. D., May, F. E., & Westley, B. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45342-7 · Cited by 381
Perren, A., Weng, L.-P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L. M., Komminoth, P., Lees, J. A., Mulligan, L. M., Mutter, G. L., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65227-3 · Cited by 378
Torres-Arzayus, M. I., de Mora, J. F., Yuan, J., Vazquez, F., Bronson, R., Rue, M., Sellers, W. R., & Brown, M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.027 · Cited by 375
Filardo, E. J. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00190-x · Cited by 373
Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use
Osborne, C. K., Zhao, H. (., & Fuqua, S. A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3172 · Cited by 367
Self-citationTranscriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor
Mazumdar, A., Wang, R.-A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R. K., & Kumar, R. (2001) · Nature Cell Biology · doi:10.1038/35050532 · Cited by 364
Kurokawa, H., Lenferink, A. E. G., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., & Arteaga, C. L. (2000) · PubMed · Cited by 363
Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout Mice
Bocchinfuso, W. P., & Korach, K. S. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026339111278 · Cited by 362
Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McCleland, R. A., Manning, D. L., & Nicholson, R. I. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.746 · Cited by 361
Self-citationEstrogen receptors α and β in the rodent mammary gland
Saji, S., Jensen, E. V., Nilsson, S., Rylander, T., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.337 · Cited by 357
pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167
Joel, P. B., Smith, J., Sturgill, T. W., Fisher, T. L., Blenis, J., & Lannigan, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1978 · Cited by 345
Lee, A. V. (1999) · Molecular Endocrinology · doi:10.1210/me.13.5.787 · Cited by 340
Self-citationHormone receptors: their role in predicting prognosis and response to endocrine therapy.
McGuire, W. L. (1978) · PubMed · Cited by 335
Elledge, R. M., Green, S., Pugh, R., Allred, D. C., Clark, G. M., Hill, J., Ravdin, P., Martino, S., & Osborne, C. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<111::aid-ijc2>3.0.co;2-w · Cited by 325
Self-citationRazandi, M., Alton, G., Pedram, A., Ghonshani, S., Webb, P., & Levin, E. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1633-1646.2003 · Cited by 323
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305
Targeted Therapy in Breast Cancer
Ross, J. S., Fletcher, J. A., Bloom, K. J., Linette, G. P., Stec, J., Symmans, W. F., Pusztai, L., & Hortobagyi, G. N. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400001-mcp200 · Cited by 303
Ferguson, A. T., Lapidus, R. G., Baylin, S. B., & Davidson, N. E. (1995) · PubMed · Cited by 297
Wu, R.-C., Qin, J., Yi, P., Wong, J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.019 · Cited by 296
Fisher, B., Anderson, S., Tan-Chiu, E., Wolmark, N., Wickerham, D. L., Fisher, E. R., Dimitrov, N. V., Atkins, J. N., Abramson, N., Merajver, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.931 · Cited by 272
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
Fan, S., Ma, Y. X., Wang, C., Yuan, R.-Q., Meng, Q., Wang, J.-A., Erdos, M., Goldberg, I. D., Webb, P., Kushner, P. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204073 · Cited by 263
Reproductive phenotypes of the progesterone receptor null mutant mouse
Lydon, J. P., DeMayo, F. J., Conneely, O. M., & O'Malley, B. W. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00254-5 · Cited by 263
Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization
Chen, D., Pace, P. E., Coombes, R. C., & Ali, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1002 · Cited by 260
McClelland, R. A., Barrow, D., Madden, T., Dutkowski, C. M., Pamment, J., Knowlden, J. M., Gee, J. M. W., & Nicholson, R. I. (2001) · Endocrinology · doi:10.1210/en.142.7.2776 · Cited by 258
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator Activity by IκB Kinase
Wu, R.-C., Qin, J., Hashimoto, Y., Wong, J., Xu, J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3549-3561.2002 · Cited by 257
Arpino, G., Green, S. J., Allred, D. C., Lew, D., Martino, S., Osborne, C. K., & Elledge, R. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0110 · Cited by 255
Self-citationLapidus, R. G., Ferguson, A. T., Ottaviano, Y. L., Parl, F. F., Smith, H. S., Weitzman, S. A., Baylin, S. B., Issa, J. J., & Davidson, N. E. (1996) · PubMed · Cited by 250
Potter, J. D., Cerhan, J. R., Sellers, T. A., McGovern, P. G., Drinkard, C. R., Kushi, L. H., & Folsom, A. R. (1995) · PubMed · Cited by 248
Horwitz, K. B., Mockus, M. B., & Lessey, B. A. (1982) · Cell · doi:10.1016/0092-8674(82)90218-5 · Cited by 246
A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm
Kumar, R., Wang, R.-A., Mazumdar, A., Talukder, A. H., Mandal, M., Yang, Z., Bagheri-Yarmand, R., Sahin, A., Hortobagyi, G., Adam, L., et al. (2002) · Nature · doi:10.1038/nature00889 · Cited by 242
Smith, C. L., Conneely, O. M., & O'Malley, B. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6120 · Cited by 242
Chen, D., Washbrook, E., Sarwar, N., Bates, G. J., Pace, P. E., Thirunuvakkarasu, V., Taylor, J., Epstein, R. J., Fuller-Pace, F. V., Egly, J.-M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205420 · Cited by 236
Osborne, C. K., Coronado, E., Allred, D. C., Wiebe, V., & DeGregorio, M. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.20.1477 · Cited by 235
Self-citationCui, X., Zhang, P., Deng, W., Oesterreich, S., Lu, Y., Mills, G. B., & Lee, A. V. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0318 · Cited by 233
Self-citationHopp, T. A., Weiss, H. L., Hilsenbeck, S. G., Cui, Y., Allred, D. C., Horwitz, K. B., & Fuqua, S. A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0141 · Cited by 220
Rogatsky, I., Trowbridge, J. M., & Garabedian, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22296 · Cited by 205
Lee, H., & Bai, W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5835-5845.2002 · Cited by 202
Molecular Cloning and Characterization of PELP1, a Novel Human Coregulator of Estrogen Receptor α
Vadlamudi, R. K., Wang, R.-A., Mazumdar, A., Sahin, A., Kumar, R., Kim, Y.-S., & Shin, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103783200 · Cited by 198
Parker, M. G. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90016-j · Cited by 194
The Loss of Estrogen and Progesterone Receptor Gene Expression in Human Breast Cancer
Lapidus, R. G., Nass, S. J., & Davidson, N. E. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018778403001 · Cited by 192
Arnold, S. F. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.24 · Cited by 190
Hong, S.-H., & Privalsky, M. L. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6612-6625.2000 · Cited by 186
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells
Lee, A. V., Weng, C.-N., Jackson, J. G., & Yee, D. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1520039 · Cited by 182
Self-citationKraus, W. L. (1993) · Molecular Endocrinology · doi:10.1210/me.7.12.1603 · Cited by 181
Cellular Functions of the Plasma Membrane Estrogen Receptor
Levin, E. R. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00192-7 · Cited by 179
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
McMahon, C., Suthiphongchai, T., DiRenzo, J., & Ewen, M. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5382 · Cited by 178
Emerging roles of MTA family members in human cancers
KUMAR, R. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.005 · Cited by 176
Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells1
Jeng, M.-H., Shupnik, M. A., Bender, T. P., Westin, E. H., Bandyopadhyay, D., Kumar, R., Masamura, S., & Santen, R. J. (1998) · Endocrinology · doi:10.1210/endo.139.10.6229 · Cited by 175
Multiple estrogen receptor assays in human breast cancer.
Hull, D. F., Clark, G. M., Osborne, C. K., Chamness, G. C., Knight, W. A., & McGuire, W. L. (1983) · PubMed · Cited by 174
Self-citationDowsett, M., Harper-Wynne, C. L., Boeddinghaus, I., Salter, J., Hills, M., Dixon, M., Ebbs, S. R., Gui, G. P., Sacks, N., & Smith, I. E. (2001) · PubMed · Cited by 172
Lopez, G. N., Turck, C. W., Schaufele, F., Stallcup, M. R., & Kushner, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010718200 · Cited by 170
Estrogen receptor corepressors -- a role in human breast cancer?
Dobrzycka, K. M., Townson, S. M., Jiang, S., & Oesterreich, S. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100517 · Cited by 160
Kurokawa, H., & Arteaga, C. L. (2003) · PubMed · Cited by 159
Arnold, S. F., Vorojeikina, D. P., & Notides, A. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30205 · Cited by 149
Truncated Estrogen Receptor α 46-kDa Isoform in Human Endothelial Cells
Figtree, G. A., McDonald, D., Watkins, H. C., & Channon, K. M. (2003) · Circulation · doi:10.1161/01.cir.0000043805.11780.f5 · Cited by 149
Oesterreich, S., Zhang, P., Guler, R. L., Sun, X., Curran, E. M., Welshons, W. V., Osborne, C. K., & Lee, A. V. (2001) · PubMed · Cited by 146
Self-citationLee, A. V., Cui, X., & Oesterreich, S. (2001) · PubMed · Cited by 146
Self-citationOsborne, C. K., & Schiff, R. (2003) · The Breast · doi:10.1016/s0960-9776(03)00137-1 · Cited by 146
Self-citationFendrick, J. L., Raafat, A. M., & Haslam, S. Z. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018766000275 · Cited by 143
Chung, Y., Sheu, M., Yang, S., Lin, C., & Yen, S. (2001) · International Journal of Cancer · doi:10.1002/ijc.1614 · Cited by 142
Progesterone Receptors in Mammary Gland Development and Tumorigenesis
Conneely, O. M., Jericevic, B. M., & Lydon, J. P. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025952924864 · Cited by 133
Winqvist, R., Hampton, G. M., Mannermaa, A., Blanco, G. A. C., Alavaikko, M. J., Kiviniemi, H., Taskinen, P. J., Evans, G. A., Wright, F. A., & Newsham, I. (1995) · PubMed · Cited by 126
Lee, A. V., Gooch, J. L., Oesterreich, S., Guler, R. L., & Yee, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1489-1496.2000 · Cited by 125
Self-citationSong, R. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.116 · Cited by 125
Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype
Garcia, J. M., Silva, J. M., Domínguez, G., Gonzalez, R. M., Navarro, A., Carretero, L., Provencio, M., España, P., & Bonilla, F. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006273516976 · Cited by 122
Akt activation by estrogen in estrogen receptor-negative breast cancer cells.
Tsai, E., Wang, S., Lee, J.-N., & Hung, M. (2001) · PubMed · Cited by 114
Lee, H., Jiang, F., Wang, Q., Nicosia, S. V., Yang, J., Su, B., & Bai, W. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0554 · Cited by 104
Vivo, I. D., Hankinson, S. E., Colditz, G. A., & Hunter, D. J. (2003) · PubMed · Cited by 98
Membrane association of estrogen receptor α mediates estrogen effect on MAPK activation
Zhang, Z., Maier, B., Santen, R. J., & Song, R. X.-D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00348-0 · Cited by 97
Multiple progesterone receptor assays in human breast cancer.
Gross, G. E., Clark, G. M., Chamness, G. C., & McGuire, W. L. (1984) · PubMed · Cited by 95
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels
Fernö, M., Stål, O., Baldetrop, B., Hatschek, T., Källström, A.-C., Malmström, P., Nordenskjöld, B. A., & Rydén, S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006332423620 · Cited by 94
A contemporary understanding of progesterone receptor function
Li, X., Lonard, D. M., & O’Malley, B. W. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.04.007 · Cited by 93
Dysregulated PTEN‐PKB and negative receptor status in human breast cancer
Shi, W., Zhang, X., Pintilie, M., Ma, N., Miller, N. A., Banerjee, D., Tsao, M., Mak, T. W., Fyles, A., & Liu, F. (2003) · International Journal of Cancer · doi:10.1002/ijc.10909 · Cited by 93
Balasenthil, S., & Vadlamudi, R. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212822200 · Cited by 92
Localization of the human progesterone receptor gene to chromosome 11q22–q23
Rousseau-Merck, M. F., Misrahi, M., Loosfelt, H., Milgröm, E., & Berger, R. (1987) · Human Genetics · doi:10.1007/bf00284486 · Cited by 85
Petz, L. N., Ziegler, Y., Schultz, J. R., & Nardulli, A. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0105 · Cited by 81
Membrane receptors for steroid hormones: Signal transduction and physiological significance
Nemere, I., Pietras, R. J., & Blackmore, P. F. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10409 · Cited by 76
Balasenthil, S., Barnes, C. J., Rayala, S. K., & Kumar, R. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.071 · Cited by 75
Bamberger, A., Milde‐Langosch, K., Schulte, H. M., & Löning, T. (2000) · Hormone Research in Paediatrics · doi:10.1159/000063434 · Cited by 75
Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women
Balleine, R. L., Earl, M. J., Greenberg, M. L., & Clarke, C. L. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690249 · Cited by 73
Advances in Endocrine Treatments for Postmenopausal Women with Metastatic and Early Breast Cancer
Buzdar, A. U. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-335 · Cited by 73
Upstream Stimulatory Factors Mediate Estrogen Receptor Activation of the Cathepsin D Promoter
Xing, W., & Archer, T. (1998) · Molecular Endocrinology · doi:10.1210/me.12.9.1310 · Cited by 72
Morelli, C., Garofalo, C., Bartucci, M., & Surmacz, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206436 · Cited by 62
Dufourny, B., van Teeffelen, H. A. A. M., Hamelers, I. H. L., Sussenbach, J. S., & Steenbergh, P. H. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660329 · Cited by 61
A mechanism of drug resistance to tamoxifen in breast cancer
Schafer, J. M., Bentrem, D. J., Takei, H., Gajdos, C., Badve, S., & Jordan, V. C. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00251-0 · Cited by 41
Roychowdhury, D. F., & Lahn, M. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.37273 · Cited by 39
Zhang, H., Hoff, H. B., & Sell, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000412200 · Cited by 38
Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells
Song, R., Santen, R. J., Kumar, R., Adam, L., Jeng, M. H., Masamura, S., & Yue, W. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00093-x · Cited by 38
Fuqua, S. A. W., Allred, D. C., Elledge, R. M., Krieg, S. L., Benedix, M. G., Nawaz, Z., O’Malley, B. W., Greene, G. L., & McGuire, W. L. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00689692 · Cited by 37
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells.
Auricchio, F., Domenico, M. D., Migliaccio, A., Castoria, G., & Bilancio, A. (1995) · PubMed · Cited by 34
The current status of aromatase inhibitors in the management of breast cancer
Baum, M., & Buzdar, A. U. (2003) · Surgical Clinics of North America · doi:10.1016/s0039-6109(03)00031-8 · Cited by 23
Mies, C., & Voigt, W. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199603000-00007 · Cited by 7
Cited by
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Mechanisms of Endocrine Resistance in Breast Cancer
Osborne, C. K., & Schiff, R. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-070909-182917 · Cited by 1,166
Self-citationFGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M. A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3746 · Cited by 732
Progesterone receptor modulates ERα action in breast cancer
Mohammed, H., Russell, I. A., Stark, R., Rueda, O. M., Hickey, T. E., Tarulli, G. A., Serandour, A. A., Birrell, S. N., Bruna, A., Saadi, A., et al. (2015) · Nature · doi:10.1038/nature14583 · Cited by 659
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
Metadata
- Authors
- Cui, X., Schiff, R., Arpino, G., Osborne, C. K., & Lee, A. V.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-10-20
- Volume
- 23
- Issue
- 30
- Pages
- 7721-7735
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2063874882
- Cited by
- 514
- References
- 142
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.